Skip to main content

Day: January 10, 2023

Israel-Based Clearmind Medicine Successfully Completes Production of CMND-100 Drug Candidate for Clinical Trial

Tel Aviv, Israel / Vancouver, Canada, Jan. 10, 2023 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (Nasdaq: CMND) (CSE: CMND) (FSE: CWY) (“Clearmind” or the “company”), a biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major undertreated health problems, announced that it has successfully manufactured batches of its drug candidate, MEAI-based molecule CMND-100, for use in its first in-human clinical trial. The trial will evaluate the psychedelic-derived drug candidate for the treatment of Alcohol Use Disorder (AUD).  “Having our drug candidate ready to be tested is a major milestone toward our first in-human clinical trial,” said Dr. Adi Zuloff-Shani, Clearmind’s Chief Executive Officer. “Our pre-clinical positive results indicated the potential of our unique treatment...

Continue reading

Grom Social Enterprises Issues Shareholder Letter and Provides Corporate Update

BOCA RATON, Fla, Jan. 10, 2023 (GLOBE NEWSWIRE) — Grom Social Enterprises, Inc. (NASDAQ: GROM) (“Grom” or the “Company”), a media, technology and entertainment company dedicated to family-friendly programming, web filtering technology and safe social media for kids, today issued a letter to shareholders from Darren Marks, its Chairman and Chief Executive Officer. Dear Fellow Shareholders, On behalf of our entire organization, we hope that you enjoyed a magical holiday season and we wish you all health, happiness, and success in the New Year. Fiscal 2022 was a foundational year for Grom as we fortified our core businesses to drive growth and future profitability. We remained steadfast to our values and primary objectives to provide safe, secure platforms and environments for kids to interact and explore; to deliver world class animation...

Continue reading

Exela Technologies Signs Strategic Partnership with Quintes Global

CHENNAI, India, Jan. 10, 2023 (GLOBE NEWSWIRE) — Exela Technologies, Inc. (“Exela”) (NASDAQ: XELA, XELAP), a global business process automation (“BPA”) leader, today announced a partnership with Quintes Global (“QG”), an innovative company with a differentiated first-of-its-kind offering of ‘Dedicated Captive Solutions’ headquartered in New Delhi, India. Exela will deploy its cloud-based Robotic Process Automation (“RPA”) solution, to enable end-to-end digitization of processes performed by QG for its customers under the unique Dedicated Captive Model. Exela provides an intuitive and fully customizable RPA solution that can be leveraged to create task-specific software bots that deploy best practices using big data, machine learning, artificial intelligence, natural language processing, and predictive analysis. The solution is...

Continue reading

Greystone Housing Impact Investors LP Announces Sales of Vantage at Stone Creek and Vantage at Coventry

OMAHA, Neb., Jan. 10, 2023 (GLOBE NEWSWIRE) — Greystone Housing Impact Investors LP (NYSE: GHI) (the “Partnership”) announced today that on January 5, 2023, Vantage at Stone Creek and Vantage at Coventry, each being a 294-unit market rate multifamily property located in Omaha, NE, were sold at the direction of the respective managing members. The Partnership’s investment in Vantage at Stone Creek was originated in March 2018 and the Partnership contributed equity totaling $7.1 million during construction. The Partnership’s investment in Vantage at Coventry was originated in September 2018 and the Partnership contributed equity totaling $8.1 million during construction. As a result of the sales, the Partnership’s equity investment in each property was redeemed. At closing of the sales, the Partnership received net cash of approximately...

Continue reading

BioSig Executes Agreement with Bellin Health for the Acquisition of its PURE EP™ Technology

Westport, CT, Jan. 10, 2023 (GLOBE NEWSWIRE) —Leading Midwest healthcare system reports significant cost savings and noise reduction following evaluation of the PURE EP™ SystemMedical center signs agreement to acquire the Company’s digital signal processing technology for arrhythmia careBioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”) an advanced digital signal processing technology company delivering unprecedented accuracy and precision to intracardiac signal visualization with its proprietary PURE EP™ System, today announced that Bellin Health System in Green Bay, Wisconsin has signed an agreement to acquire the Company’s PURE EP™ System. The agreement follows a 60-day formal evaluation of the PURE EP™ System at Bellin Health. The hospital reported that the PURE EP™...

Continue reading

TEN, Ltd. to Participate at Capital Link’s Corporate Presentation Series

ATHENS, Greece, Jan. 10, 2023 (GLOBE NEWSWIRE) — TEN, Ltd. (“TEN” or the “Company”) (NYSE:TNP) a leading diversified crude, product and LNG tanker operator, today announced that it will participate in Capital Link’s Corporate Presentation Series. On Thursday, January 12th, 2023, at 10:00 am EST its senior management team will go through a presentation on the company’s current operations, business development, growth prospects and outlook of the crude, product and LNG tanker sectors. You can register for the webinar below:Date: Thursday, January 12, 2023Time: 10:00 am EST   Speakers: Dr. Nikolas P. Tsakos, Founder, President & CEOGeorge Saroglou, Chief Operating OfficerHarrys Kosmatos, Corporate Development OfficerApostolos Tsitsirakis, Strategy & Corporate Development   Register: https://webinars.capitallink.com/2023/company_presentation/On...

Continue reading

Update – Maha Energy invites to an Investor Meeting

Maha Energy AB (publ) today announces that there will be an Investor Meeting for any shareholders or other interested parties on Monday February 6th in Stockholm, Sweden On February 6th, 2023, Maha Energy invites you to a lunch Investor Meeting (this was previously announced as a breakfast meeting, but the time has now been changed, as has the venue). There will be a presentation from the Company, and you will have a chance to ask questions. CEO Paulo Thiago Mendonça, CFO Bernardo Guterres and COO Alan Johnson will be there for the presentation and a Q&A. The presentation will be held in English. The presentation will also stream live on YouTube – view presentation here:https://www.youtube.com/watch?v=bqM7w2ki9QI Program February 6th (CET)12:30 – 13:00: Registration and a lighter Lunch13:00 – 14:00: Company presentation by CEO Paulo...

Continue reading

POET Technologies Announces Production Release of Optical Engines for 100G, 200G and 400G for Telecom and Data Center Market

Achievement marks commercialization milestone for products built with proprietary wafer-level chip-scale packaging technology TORONTO, Jan. 10, 2023 (GLOBE NEWSWIRE) — POET Technologies Inc. (“POET” or the “Company”) (TSX Venture: PTK; NASDAQ: POET), the designer and developer of the POET Optical Interposer™ and Photonic Integrated Circuits (PICs) for the data center, tele-communication and artificial intelligence markets, today announced that it has released to production four optical engines, an achievement that advances the Company’s commercialization goals. The small form factor optical engines with integrated directly modulated lasers (DMLs), optical multiplexer, high-speed photodiodes and optical demultiplexer enable low power, cost-efficient and highly scalable 100G CWDM4, 200G FR4 and 400G FR4 pluggable transceivers...

Continue reading

Dassault Systèmes: Half-year statement of the Liquidity contract entered into with Oddo BHF SCA

Press ReleaseVELIZY-VILLACOUBLAY, France — January 10, 2023 Half-year statement of the Liquidity contract entered into with Oddo BHF SCA Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA) announces that the following resources appeared on December 31, 2022 on the liquidity contract entered into with Oddo BHF SCA implemented on January 7, 2015 and updated on June 18, 2019:         712,286 Dassault Systèmes shares, and € 7,510,217.05 in cash.It is reminded that:       1.   at the time of the implementation of the liquidity contract, the following resources appeared on the liquidity account:0 Dassault Systèmes shares;€ 10,000,000 in cash.       2.   Pursuant to the amendment dated October 26, 2017, an additional contribution of € 5,000,000 was made, increasing from € 10,000,000 to € 15,000,000 the resources of the liquidity...

Continue reading

Inspire Medical Systems, Inc. to Report Fourth Quarter and Fiscal 2022 Financial Results on February 7, 2023

MINNEAPOLIS, Jan. 10, 2023 (GLOBE NEWSWIRE) — Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire) will release financial results for the fourth quarter and fiscal 2022 after the close of trading on Tuesday, February 7. Inspire’s management team will host a corresponding conference call beginning at 5:00 p.m. Eastern Time to discuss the financial results and recent business developments. A webcast of the call will be accessible via the Investor Relations page of the Inspire website or through this link: Inspire’s Q4 2022 earnings call webcast. For those not planning to ask a question of management, the Company recommends listening via the webcast. If you plan to ask a question, please use the following link: Inspire’s Q4 2022 earnings call. After registering, an email will be sent, including dial-in details and a unique...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.